Literature DB >> 22227485

Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease.

Safinaz Mostafa1, Vanessa Seamon, Ana Maria Azzarolo.   

Abstract

Sjögren's syndrome (SS) is a chronic autoimmune disease characterized by lymphocytic infiltration, destruction of lacrimal and salivary glands and the presence of serum autoantibodies. Most women that suffer from SS are post-menopausal however, not all post-menopausal women develop SS, suggesting that other factors, in addition to the decrease in ovarian hormones, are necessary for the development of SS. The purposes of this study were to investigate a) the time course of lymphocytic infiltration and apoptosis in the lacrimal gland after ovariectomy, b) if a predisposed genetic background for SS aggravates the effects of decreasing levels of sex hormones in the lacrimal glands and c) if physiological doses of estrogen or androgen prevent the effects observed after ovariectomy. Six weeks old mice that are genetically predisposed to SS (NOD.B10.H2(b)) and control (C57BL/10) mice were either sham operated, ovariectomized (OVX), OVX + 17β estradiol (E(2)) or OVX + Dihydrotestosterone (DHT). Lacrimal glands were collected at 3, 7, 21 or 30 days after surgery and processed for immunohistochemistry to measure CD4(+), CD8(+) T cells, B220(+) B cells, nuclear DNA degradation and cleaved caspase-3 activity. Quantification of the staining was done by light microscopy and Image Pro Plus software. The results of our study show that lymphocytic infiltration preceded lacrimal gland apoptosis after ovariectomy. Moreover, removal of ovarian sex hormones accelerated these effects in the genetically predisposed animal and these effects were more severe and persistent compared to control animals. In addition, sex hormone replacement at physiological levels prevented these symptoms. The mechanisms by which decreased levels of sex hormones caused lymphocytic infiltration and apoptosis and the interaction of lack of sex hormones with the genetic elements remain to be elucidated. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22227485      PMCID: PMC3296912          DOI: 10.1016/j.exer.2011.12.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  38 in total

1.  Androgen support of lacrimal gland function.

Authors:  A M Azzarolo; A K Mircheff; R L Kaswan; F Z Stanczyk; E Gentschein; L Becker; B Nassir; D W Warren
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

2.  The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.

Authors:  D I Mitsias; A G Tzioufas; C Veiopoulou; E Zintzaras; I K Tassios; O Kogopoulou; H M Moutsopoulos; G Thyphronitis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 3.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

4.  G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium.

Authors:  K Maiti; J W Paul; M Read; E C Chan; S C Riley; P Nahar; R Smith
Journal:  Endocrinology       Date:  2011-03-22       Impact factor: 4.736

5.  Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues.

Authors:  E M Rocha; L A Wickham; L A da Silveira; K L Krenzer; F S Yu; I Toda; B D Sullivan; D A Sullivan
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

6.  Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis.

Authors:  N Ishimaru; K Saegusa; K Yanagi; N Haneji; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

7.  Do Genetic Alterations in Sex Steroid Receptors Contribute to Lacrimal Gland Disease in Sjögren's Syndrome?

Authors:  Stephen M Richards; David A Sullivan
Journal:  Open Endocrinol J       Date:  2009

Review 8.  Dry eye syndromes.

Authors:  Stefano Barabino; M Reza Dana
Journal:  Chem Immunol Allergy       Date:  2007

9.  Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor alpha and interferon gamma.

Authors:  Makoto Kamachi; Atsushi Kawakami; Satoshi Yamasaki; Ayumi Hida; Tomoki Nakashima; Hideki Nakamura; Hiroaki Ida; Masako Furuyama; Koto Nakashima; Kazutaka Shibatomi; Taiichiro Miyashita; Kiyoshi Migita; Katsumi Eguchi
Journal:  J Lab Clin Med       Date:  2002-01

10.  Suppression of lymphocyte proliferation and regulation of dendritic cell phenotype by soluble mediators from rat lacrimal epithelial cells.

Authors:  M de Saint Jean; T Nakamura; Y Wang; M D Trousdale; J E Schechter; A K Mircheff
Journal:  Scand J Immunol       Date:  2009-07       Impact factor: 3.487

View more
  21 in total

1.  GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome.

Authors:  Sabrina Lisi; Margherita Sisto; Dario Domenico Lofrumento; Massimo D'Amore; Raffaella De Lucro; Domenico Ribatti
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 2.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 3.  The impact of combined oral contraceptives on ocular tissues: a review of ocular effects.

Authors:  Marilita M Moschos; Eirini Nitoda
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

Review 4.  Mouse Models of Primary Sjogren's Syndrome.

Authors:  Young-Seok Park; Adrienne E Gauna; Seunghee Cha
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients.

Authors:  Clara Chivasso; Veronika Nesverova; Michael Järvå; Anne Blanchard; Kristie L Rose; Fredrik Kryh Öberg; Zhen Wang; Maud Martin; Florent Lhotellerie; Egor Zindy; Bruna Junqueira; Karelle Leroy; Benoit Vanhollebeke; Valérie Delforge; Nargis Bolaky; Jason Perret; Muhammad Shahnawaz Soyfoo; Stefania Moscato; Chiara Baldini; François Chaumont; Letizia Mattii; Kevin L Schey; Yvonne Myal; Susanna Törnroth-Horsefield; Christine Delporte
Journal:  Cells       Date:  2021-08-17       Impact factor: 7.666

6.  Mastitis associated with Sjögren's syndrome: a series of nine cases.

Authors:  Radjiv Goulabchand; Assia Hafidi; Ingrid Millet; Jacques Morel; Cédric Lukas; Sébastien Humbert; Sophie Rivière; Christian Gény; Christian Jorgensen; Alain Le Quellec; Hélène Perrochia; Philippe Guilpain
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Does estrogen deficiency cause lacrimal gland inflammation and aqueous-deficient dry eye in mice?

Authors:  Raheleh Rahimi Darabad; Tomo Suzuki; Stephen M Richards; Frederick A Jakobiec; Fouad R Zakka; Stefano Barabino; David A Sullivan
Journal:  Exp Eye Res       Date:  2014-07-30       Impact factor: 3.467

8.  Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.

Authors:  Stefanie Czerwinski; Safinaz Mostafa; Vanessa Seamon Rowan; Ana Maria Azzarolo
Journal:  Exp Eye Res       Date:  2014-09-11       Impact factor: 3.467

9.  Effect of Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood on reproductive endocrine activity and immune functions in patients with primary Sjogren's syndrome.

Authors:  Guo-lin Wu; Na-yuan Wu; Tian-yi Li; Yong-sheng Fan; Guo-you Yu; Wen-wen Lu
Journal:  Chin J Integr Med       Date:  2015-11-03       Impact factor: 1.978

10.  Evaluation of dry eye and Meibomian gland dysfunction in female androgenetic alopecia patients.

Authors:  Pelin Kiyat; Melis Palamar; Bengu Gerceker Turk; Ayse Yagci
Journal:  Int Ophthalmol       Date:  2021-07-09       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.